Analysts from Royal Bank of Canada, Mizuho Securities, and Leerink partners issued rating and target price updates for Medtronic shares.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts from Royal Bank of Canada, Mizuho Securities, and Leerink partners issued rating and target price updates for Medtronic shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
-
Mizuho Securities
Japanese investment banking company
Related events
- Mizuho Securities increased its price objective, while Citigroup reaffirmed its market outperform rating for a stock, with MarketBeat reporting the average rating.
- Raymond James Financial cut shares from strong-buy to outperform, lowering price targets and setting outperform ratings for Interfor Co. on June 29, 2026.
- Banks like Mizuho, Deutsche Bank, and Goldman Sachs maintained or raised ratings for Harmony Biosciences, citing benefits from tariffs and onshoring trends for AI stocks.